Table 3. Follow-up colonoscopic findings.
Outcome | Low ANXA10 at baseline colonoscopy | High ANXA10 at baseline colonoscopy | HR (95% CI) | P value |
---|---|---|---|---|
(N=67) | (N=112) | |||
HPs | 26 (38.8) | 37 (33.0) | 1.04 (0.62, 1.7) | 0.89 |
Proximal HPs | 8 (11.9) | 7 (6.3) | 0.66 (0.24, 1.8) | 0.43 |
HP above rectosigmoid | 9 (13.4) | 10 (8.9) | 0.83 (0.34, 2.0) | 0.68 |
SSPs | 5 (7.5) | 19 (17.0) | 2.7 (1.01, 7.0) | 0.048 |
Proximal SSPs | 3 (4.5) | 18 (16.1) | 4.0 (1.3, 13.0) | 0.02 |
SSP with dysplasia or ≥10 mm | 1 (1.5) | 4 (3.6) | 2.5 (0.32, 18.6) | 0.38 |
SSP or HP above rectosigmoid | 13 (19.4) | 27 (24.1) | 1.5 (0.79, 3.0) | 0.21 |
Any adenomas | 13 (19.4) | 21 (18.8) | 1.2 (0.62, 2.5) | 0.55 |
Any advanced adenomas | 2 (3.0) | 5 (4.5) | 1.8 (0.36, 9.0) | 0.47 |
ANXA10, Annexin 10; CI, confidence interval; HP, hyperplastic polyp; HR, hazard ratio; SSP, sessile serrated polyp.
Values are presented as N (%). HR and P values correspond to univariable Cox regression models for each outcome.